Patents by Inventor Renaud Louis Benoit PERRIN

Renaud Louis Benoit PERRIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220386596
    Abstract: This invention relates to a mixture of an alkyl polyglucoside with a (biological performance improving) adjuvant which is a non-ionic surfactant, the mixture improving the biological performance of an agrochemical. The biological performance effect of the alkyl polyglucoside is poorer than the partner adjuvant but the biological performance effect of the mixture is as good as that delivered by a much larger amount of that better, partner adjuvant alone.
    Type: Application
    Filed: August 18, 2022
    Publication date: December 8, 2022
    Applicant: SYNGENTA PARTICIPATIONS AG
    Inventors: Gordon Alastair BELL, Renaud Louis Benoit PERRIN, Niall Rae THOMSON
  • Patent number: 11464226
    Abstract: This invention relates to a mixture of an alkyl polyglucoside with a (biological performance improving) adjuvant which is a non-ionic surfactant, the mixture improving the biological performance of an agrochemical. The biological performance effect of the alkyl polyglucoside is poorer than the partner adjuvant but the biological performance effect of the mixture is as good as that delivered by a much larger amount of that better, partner adjuvant alone.
    Type: Grant
    Filed: October 12, 2017
    Date of Patent: October 11, 2022
    Assignee: SYNGENTA PARTICIPATIONS AG
    Inventors: Gordon Alastair Bell, Renaud Louis Benoit Perrin, Niall Rae Thomson
  • Publication number: 20190254275
    Abstract: This invention relates to a mixture of an alkyl polyglucoside with a (biological performance improving) adjuvant which is a non-ionic surfactant, the mixture improving the biological performance of an agrochemical. The biological performance effect of the alkyl polyglucoside is poorer than the partner adjuvant but the biological performance effect of the mixture is as good as that delivered by a much larger amount of that better, partner adjuvant alone.
    Type: Application
    Filed: October 12, 2017
    Publication date: August 22, 2019
    Applicant: SYNGENTA PARTICIPATIONS AG
    Inventors: Gordon Alastair BELL, Renaud Louis Benoit PERRIN, Niall Rae THOMSON